# VOR BIOPHARMA INC (VORXXXX)

> Institutional ownership reported to the SEC as of Q3 2025, from Form 13F filings. Source: https://holderbook.com/stocks/VORXXXX/

- Reporting holders: 1
- Reported value: $2.6M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [JOHNSON & JOHNSON](https://holderbook.com/funds/200406-johnson-johnson/) | $2.6M | 53,732 | 0.5% | 17 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2025 | 1 | $2.6M |
| Q2 2025 | 38 | $99.1M |
| Q1 2025 | 44 | $43.1M |
| Q4 2024 | 51 | $67.7M |
| Q3 2024 | 53 | $33.5M |
| Q2 2024 | 69 | $54.5M |
| Q1 2024 | 68 | $140.3M |
| Q4 2023 | 60 | $134.6M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 70 | $187.9M |
| Q1 2023 | 60 | $367.9M |
| Q4 2022 | 58 | $400.5M |